Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare read-only, idempotent, open-world, non-destructive, so safety needs no restating. The description instead adds behavior the annotations cannot: results are sorted newest first, records contain the product/reason/firm/FDA class/sales area in the agency's own words, and free-tier data is capped at 14 days. Pagination or truncation behavior is left unstated.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.